Colleen Cebulla M MD, PhD

Colleen Cebulla M MD, PhD
Assoc ProfessorCollege of
5020 OSU Eye & Ear Institute 915 Olentangy River Road Columbus Ohio 43212
Phone:614-652-2600Fax: (614) 652-2610
  • Molecular Biology and Cancer Genetics

Research Description

In addition to seeing patients, Dr. Cebulla is actively engaged in both basic and clinical. The focus of Dr. Cebulla's lab is translational research on retinal detachments and uveal melanoma. Also, a collaborative group with Dr. Cebulla, Dr. Mohammed Abdel-Rahman and Dr. Frederick Davidorf has identified that over 10% of patients with uveal melanoma have a heritable cancer syndrome. They are working hard to identify the genes responsible for increased cancer in the family and have identified a new cancer syndrome due to mutation in the BAP1 gene. They are currently involved in understanding factors which influence survival with metastatic disease and on targeted therapy for melanoma.

Current Publications

  • Martorano LM, Winkelmann RR, Cebulla CM, Abdel-Rahman MH, Campbell SMOcular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.Int J Dermatol 53 657-63 6/1/2014
  • Kim B, Abdel-Rahman MH, Wang T, Pouly S, Mahmoud AM, Cebulla CMRetinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment.Invest Ophthalmol Vis Sci 55 2031-40 4/1/2014
  • Pilarski R, Cebulla CM, Massengill JB, Rai K, Rich T, Strong L, McGillivray B, Asrat MJ, Davidorf FH, Abdel-Rahman MHExpanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.Genes Chromosomes Cancer 53 177-82 2/1/2014
  • Lubow M, Cebulla CMCharles Bonnet syndrome and Terson's syndrome: good news from bad news.Graefes Arch Clin Exp Ophthalmol 251 2257 9/1/2013

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: